← All Sponsors
SPONSOR

Kafrelsheikh University

Total Trials
9
Recruiting
9
Phases
Phase 3

Kafrelsheikh University is a clinical research sponsor with 9 registered studies on ClinicalTrials.gov, of which 9 are actively recruiting participants. Research covers conditions including Immediate Implant Placement, Ischemic Stroke, Neuropathy, Facial, Bell Palsy.

The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Kafrelsheikh University

How many clinical trials has Kafrelsheikh University sponsored?
ClinicalMetric currently tracks 9 clinical trials sponsored by Kafrelsheikh University, of which 9 are actively recruiting participants. These trials cover conditions including Immediate Implant Placement, Ischemic Stroke, Neuropathy, Facial. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Kafrelsheikh University research focus on?
Kafrelsheikh University clinical trials span Immediate Implant Placement, Ischemic Stroke, Neuropathy, Facial, Bell Palsy, Laser, and additional conditions. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Kafrelsheikh University clinical trial?
To participate in a Kafrelsheikh University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Kafrelsheikh University trials with current recruitment status updated daily.

Clinical Trials by Kafrelsheikh University

NCT06863051
Recruiting

Effect of Albumin Platelet-Rich Fibrin or Leucocyte- Platelet-Rich Fibrin on Immediate Implant

Immediate Implant Placement
NCT06591338 Phase 3
Recruiting

Combining Aspirin With Ticagrelor or Clopidogrel in Large-vessel Minor Stroke or TIA

Ischemic Stroke
NCT06202755 Phase 3
Recruiting

Ticagrelor Versus Cilostazol in Large-vessel Ischemic Stroke

Ischemic Stroke
NCT07519421
Recruiting

Different Laser Frequencies on Neuropathic Outcomes in Patients With Bell's Palsy

Neuropathy, Facial
NCT06591312 Phase 3
Recruiting

Combining Aspirin With Ticagrelor or Clopidogrel in Minor Stroke or TIA

Ischemic Stroke
NCT06642285
Recruiting

Effect of Implementing Evidence Based Practices on Prevention of Associated Nasal Pressure Injuries Among Preterm Neonates With Non-Invasive Respiratory Support

Mechanical Ventilation Complication
NCT06757218
Recruiting

Post Extraction Changes After Alveolar Socket Preservation Using Autogenous Dentin Graft (ADG) Combined With Either Albumin Platelet-rich Fibrin (ALB-PRF) or Standard Platelet-rich Fibrin (PRF).

Alveolar Socket Preservation
NCT06591299 Phase 3
Recruiting

Combining Aspirin With Cilostazol or Clopidogrel in Minor Stroke or TIA

Ischemic Stroke
NCT06966674
Recruiting

No-Reflow in Patients With STEMI After Intracoronary Tirofiban After Opening of the Track

No-Reflow
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology